{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:20Z","timestamp":1787032820372,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,10]]},"DOI":"10.7759\/cureus.30142","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:27:12Z","timestamp":1665412032000},"source":"Crossref","is-referenced-by-count":1,"title":["Angioedema of Vermilion Border Lip: A Case Report"],"prefix":"10.7759","author":[{"given":"Karthik","family":"Rajaram Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Chinnakutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaki","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarathchandra","family":"Govind Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh Kumar","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2021.09.002","article-title":"Hereditary angioedema","volume":"40","author":"Wilkerson RG","year":"2022","unstructured":"Wilkerson RG, Moellman JJ. Hereditary angioedema. Emerg Med Clin North Am. 2022, 40:99-118. 10.1016\/j.emc.2021.09.002","journal-title":"Emerg Med Clin North Am"},{"key":"ref2","unstructured":"Angioedema. (2022). Accessed. September 26, 2022: https:\/\/pubmed.ncbi.nlm.nih.gov\/30860724\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S27566","article-title":"Hereditary angioedema: epidemiology, management, and role of icatibant","volume":"7","author":"Ghazi A","year":"2013","unstructured":"Ghazi A, Grant JA. Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics. 2013, 7:103-13. 10.2147\/BTT.S27566","journal-title":"Biologics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100627","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update","volume":"15","author":"Maurer M","year":"2022","unstructured":"Maurer M, Magerl M, Betschel S, et al.. The international WAO\/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. World Allergy Organ J. 2022, 15:100627. 10.1016\/j.waojou.2022.100627","journal-title":"World Allergy Organ J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000104226","article-title":"Tacrolimus-induced intestinal angioedema: diagnosis by capsule endoscopy","volume":"1","author":"Zvidi I","year":"2007","unstructured":"Zvidi I, Gal E, Rachamimov R, Niv Y. Tacrolimus-induced intestinal angioedema: diagnosis by capsule endoscopy. Case Rep Gastroenterol. 2007, 1:1-6. 10.1159\/000104226","journal-title":"Case Rep Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2017.09.014","article-title":"Small bowel angioedema from angiotensin-converting enzyme: changes on computed tomography","volume":"13","author":"Vallabh H","year":"2018","unstructured":"Vallabh H, Hahn B, Bryan C, Hogg J, Kupec JT. Small bowel angioedema from angiotensin-converting enzyme: changes on computed tomography. Radiol Case Rep. 2018, 13:55-7. 10.1016\/j.radcr.2017.09.014","journal-title":"Radiol Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-016-8539-6","article-title":"\u201cNuts and bolts\u201d of laboratory evaluation of angioedema","volume":"51","author":"Farkas H","year":"2016","unstructured":"Farkas H, Veszeli N, Kajd\u00e1csi E, Cervenak L, Varga L. \u201cNuts and bolts\u201d of laboratory evaluation of angioedema. Clin Rev Allergy Immunol. 2016, 51:140-51. 10.1007\/s12016-016-8539-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000481256","article-title":"Endocan: a novel marker of endothelial dysfunction in C1-inhibitor-deficient hereditary angioedema","volume":"174","author":"Demirturk M","year":"2017","unstructured":"Demirturk M, Akpinar TS, Kose M, Gelincik A, Colako\u011flu B, Buyukozturk S. Endocan: a novel marker of endothelial dysfunction in C1-inhibitor-deficient hereditary angioedema. Int Arch Allergy Immunol. 2017, 174:104-7. 10.1159\/000481256","journal-title":"Int Arch Allergy Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.06.037","article-title":"Hereditary angioedema: safety of long-term stanozolol therapy","volume":"120","author":"Sloane DE","year":"2007","unstructured":"Sloane DE, Lee CW, Sheffer AL. Hereditary angioedema: safety of long-term stanozolol therapy. J Allergy Clin Immunol. 2007, 120:654-8. 10.1016\/j.jaci.2007.06.037","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.03.007","article-title":"Predictors of severe anaphylaxis in Hymenoptera venom allergy: the importance of absence of urticaria and angioedema","volume":"125","author":"Chapsa M","year":"2020","unstructured":"Chapsa M, Roensch H, Langner M, Beissert S, Bauer A. Predictors of severe anaphylaxis in Hymenoptera venom allergy: the importance of absence of urticaria and angioedema. Ann Allergy Asthma Immunol. 2020, 125:72-7. 10.1016\/j.anai.2020.03.007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork K","year":"2008","unstructured":"Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008, 100:153-61. 10.1016\/S1081-1206(10)60424-3","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"Us HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse PJ","year":"2021","unstructured":"Busse PJ, Christiansen SC, Riedl MA, et al.. Us HAEA Medical Advisory Board 2020 guidelines for the management of hereditary angioedema. J Allergy Clin Immunol Pract. 2021, 9:132-50.e3. 10.1016\/j.jaip.2020.08.046","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu DK","year":"2019","unstructured":"Chu DK, Wood RA, French S, et al.. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019, 393:2222-32. 10.1016\/S0140-6736(19)30420-9","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.10.029","article-title":"Tranexamic acid for ACE inhibitor induced angioedema - a case report","volume":"43","author":"Wang K","year":"2020","unstructured":"Wang K, Geiger H, McMahon A. Tranexamic acid for ACE inhibitor induced angioedema - a case report. Am J Emerg Med. 2020, 43:292.e5-e7. 10.1016\/j.ajem.2020.10.029","journal-title":"Am J Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01206-w","article-title":"Lanadelumab: a review in hereditary angioedema","volume":"79","author":"Syed YY","year":"2019","unstructured":"Syed YY. Lanadelumab: a review in hereditary angioedema. Drugs. 2019, 79:1777-84. 10.1007\/s40265-019-01206-w","journal-title":"Drugs"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14075","article-title":"Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic\/spontaneous urticaria: analyses according to the presence or absence of angioedema","volume":"31","author":"Maurer M","year":"2017","unstructured":"Maurer M, Sofen H, Ortiz B, Kianifard F, Gabriel S, Bernstein JA. Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic\/spontaneous urticaria: analyses according to the presence or absence of angioedema. J Eur Acad Dermatol Venereol. 2017, 31:1056-63. 10.1111\/jdv.14075","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118161-angioedema-of-vermilion-border-lip-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:49:40Z","timestamp":1707490180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118161-angioedema-of-vermilion-border-lip-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.30142","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}